Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $850.02 | 52 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $335.70 | 22 | $0 (2024) |
| Amgen Inc. | $103.22 | 6 | $0 (2024) |
| Novo Nordisk Inc | $98.83 | 5 | $0 (2024) |
| Lilly USA, LLC | $90.04 | 5 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $63.88 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $49.23 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $29.15 | 1 | $0 (2023) |
| Eisai Inc. | $20.70 | 1 | $0 (2024) |
| Abbott Laboratories | $18.31 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15.88 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.47 | 7 | Novo Nordisk Inc ($40.14) |
| 2023 | $419.45 | 26 | ABBVIE INC. ($217.21) |
| 2022 | $143.04 | 9 | ABBVIE INC. ($61.95) |
| 2021 | $156.06 | 10 | Lilly USA, LLC ($90.04) |
All Payment Transactions
52 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Neuromodulation | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neurology | ||||||
| 02/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation | ||||||
| 12/12/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Inflammation | ||||||
| 09/12/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/17/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: NEUROSCIENCE | ||||||
| 07/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 3 | 53 | 65 | $9,767 | $1,576 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 17 | 21 | $3,633 | $635.41 | 17.5% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 18 | 26 | $2,912 | $585.86 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 18 | $3,222 | $354.59 | 11.0% |
About Charles Powers, PA
Charles Powers, PA is a Physician Assistant healthcare provider based in Durant, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114952678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Powers, PA has received a total of $850.02 in payments from pharmaceutical and medical device companies, with $131.47 received in 2024. These payments were reported across 52 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($850.02).
As a Medicare-enrolled provider, Powers has provided services to 53 Medicare beneficiaries, totaling 65 services with total Medicare billing of $1,576. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Durant, OK
- Active Since 07/12/2006
- Last Updated 09/03/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1114952678
Products in Payments
- VRAYLAR (Drug) $248.04
- Otezla (Drug) $103.22
- UBRELVY (Drug) $87.66
- Ozempic (Drug) $79.27
- EMGALITY (Drug) $68.20
- XIFAXAN (Drug) $63.88
- TRELEGY ELLIPTA (Drug) $49.23
- REXULTI (Drug) $29.15
- TRULICITY (Drug) $21.84
- Leqembi (Drug) $20.70
- Rybelsus (Drug) $19.56
- PROCLAIM (Device) $18.31
- AIRSUPRA (Drug) $15.88
- INTELLIS ADAPTIVESTIM (Device) $13.36
- ENTRESTO (Drug) $11.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Durant
Cynthia Noble, Pa-C, PA-C
Physician Assistant — Payments: $6,006
Michelle Jennings, Pa-C, PA-C
Physician Assistant — Payments: $183.74
Anna Hansen, Pa-C, PA-C
Physician Assistant — Payments: $121.93
Jeffrey Hamblin, P.a.-C, P.A.-C
Physician Assistant — Payments: $47.30
Marty Viefhaus, Pa-C, PA-C
Physician Assistant — Payments: $19.92
Jeffrey Williams, Pac, PAC
Physician Assistant — Payments: $11.98